Lipoprotein associated- phospholipase A2 in STEMI vs. NSTE-ACS patients: a marker of cardiovascular atherosclerotic risk rather than thrombosis.

Monica VerdoiaRoberta RollaRocco GiosciaAndrea RognoniGiuseppe De Lucanull null

Published in: Journal of thrombosis and thrombolysis (2023)

The present study shows that among ACS patients, the levels of Lp-PlA2 are inversely associated with STEMI presentation and thrombotic coronary occlusion, being instead increased in NSTE-ACS patients, therefore potentially representing a marker of more aggressive chronic cardiovascular disease with an increased risk of recurrent cardiovascular events.

Keyphrases

cardiovascular disease
end stage renal disease
cardiovascular events
newly diagnosed
ejection fraction
acute coronary syndrome
prognostic factors
chronic kidney disease
metabolic syndrome
atrial fibrillation
percutaneous coronary intervention
coronary artery
patient reported outcomes
type diabetes
aortic valve